Efthymios Kyrodimos

1.8k total citations · 1 hit paper
85 papers, 1.1k citations indexed

About

Efthymios Kyrodimos is a scholar working on Oncology, Otorhinolaryngology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Efthymios Kyrodimos has authored 85 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Oncology, 26 papers in Otorhinolaryngology and 22 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Efthymios Kyrodimos's work include Head and Neck Cancer Studies (18 papers), Cancer-related Molecular Pathways (8 papers) and Voice and Speech Disorders (6 papers). Efthymios Kyrodimos is often cited by papers focused on Head and Neck Cancer Studies (18 papers), Cancer-related Molecular Pathways (8 papers) and Voice and Speech Disorders (6 papers). Efthymios Kyrodimos collaborates with scholars based in Greece, United Kingdom and United States. Efthymios Kyrodimos's co-authors include Alexandros G. Georgakilas, Athanasia Pavlopoulou, Michail Nikolaou, Aristides Sismanis, Nicholas Mastronikolis, Aristeidis Chrysovergis, Evangelos Tsiambas, Vasileios Papanikolaou, Vasileios Ragos and Amanda Psyrri and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Molecular Sciences and Pharmacology & Therapeutics.

In The Last Decade

Efthymios Kyrodimos

75 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The challenge of drug resistance in cancer treatment: a current overview

2018 432 citations Michail Nikolaou, Athanasia Pavlopoulou et al. Clinical & Experimental Metastasis profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Efthymios Kyrodimos Greece	15	420	252	214	211	150	85	1.1k
Lojze Šmid Slovenia	21	297 0.7×	244 1.0×	230 1.1×	287 1.4×	201 1.3×	58	1.2k
Qinglong Li China	20	425 1.0×	189 0.8×	195 0.9×	25 0.1×	135 0.9×	63	1.3k
Dae Young Hur South Korea	26	830 2.0×	453 1.8×	231 1.1×	40 0.2×	109 0.7×	102	1.8k
Shiming Chen China	23	890 2.1×	208 0.8×	401 1.9×	96 0.5×	209 1.4×	121	1.8k
Sohtaro Komiyama Japan	23	561 1.3×	542 2.2×	168 0.8×	185 0.9×	152 1.0×	71	1.5k
Tong Wu China	22	792 1.9×	298 1.2×	422 2.0×	43 0.2×	200 1.3×	88	1.5k
Hyun Ji Kim South Korea	18	424 1.0×	208 0.8×	135 0.6×	37 0.2×	89 0.6×	66	1.1k
Wan Du China	25	1.0k 2.4×	603 2.4×	494 2.3×	51 0.2×	239 1.6×	45	2.0k
Jianqiang Chen China	16	623 1.5×	187 0.7×	140 0.7×	52 0.2×	101 0.7×	43	1.1k
Safiye Aktaş Türkiye	18	421 1.0×	270 1.1×	209 1.0×	14 0.1×	144 1.0×	137	1.2k

Countries citing papers authored by Efthymios Kyrodimos

Since Specialization

Citations

This map shows the geographic impact of Efthymios Kyrodimos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Efthymios Kyrodimos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Efthymios Kyrodimos more than expected).

Fields of papers citing papers by Efthymios Kyrodimos

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Efthymios Kyrodimos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Efthymios Kyrodimos. The network helps show where Efthymios Kyrodimos may publish in the future.

Co-authorship network of co-authors of Efthymios Kyrodimos

This figure shows the co-authorship network connecting the top 25 collaborators of Efthymios Kyrodimos. A scholar is included among the top collaborators of Efthymios Kyrodimos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Efthymios Kyrodimos. Efthymios Kyrodimos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Matsopoulos, George K., et al.. (2025). The Application of Radiomics in Laryngeal Cancer Management: A Scoping Review of the Literature. The Laryngoscope. 136(4). 1614–1626.

Kyrodimos, Efthymios, et al.. (2025). The Contribution of Voice Therapy to Voice Quality and Quality of Life in Patients With Early Glottic Cancer Treated With Transoral CO2 Laser Microsurgery. Journal of Voice.

Samara, Pinelopi, George Agrogiannis, Ioannis Athanasopoulos, et al.. (2025). Releasing the brakes: the role of immune checkpoint inhibitors in laryngeal cancer. Exploration of Targeted Anti-tumor Therapy. 6. 1002292–1002292. 1 indexed citations

Katsas, Konstantinos, et al.. (2025). Prognostic value of systemic inflammatory markers in head and neck squamous cell carcinoma. European Archives of Oto-Rhino-Laryngology. 283(1). 371–381.

Logotheti, Stella, Athanasia Pavlopoulou, Anne-Marie Galow, et al.. (2024). Intercellular pathways of cancer treatment-related cardiotoxicity and their therapeutic implications: the paradigm of radiotherapy. Pharmacology & Therapeutics. 260. 108670–108670. 2 indexed citations

Chrysovergis, Aristeidis, Panagiotis Stathopoulos, Evangelos Tsiambas, et al.. (2024). Clinical Impact of C-myc Oncogenic Diversity on Solid and Lymphoid Malignancies. MAEDICA – a Journal of Clinical Medicine. 19(2). 355–359. 1 indexed citations

Kyrodimos, Efthymios, et al.. (2024). The Oncologic Value of Transoral Resection in Early-Stage Laryngeal Squamous Cell Carcinoma of the Glottis: A Retrospective Study. Cureus. 16(9). e69975–e69975. 1 indexed citations

Kyrodimos, Efthymios, et al.. (2024). Photon vs. proton radiation therapy in head and neck cancer: a review of dosimetric advantages and patient quality of life. Journal of Cancer Metastasis and Treatment.

Exarchos, Themis P., et al.. (2024). Lip-Reading Advancements: A 3D Convolutional Neural Network/Long Short-Term Memory Fusion for Precise Word Recognition. SHILAP Revista de lepidopterología. 4(1). 410–422. 8 indexed citations

10.

Nicolatou‐Galitis, Ourania, Amanda Psyrri, Nikolaos Tsoukalas, et al.. (2023). Oral Toxicities in Cancer Patients, Who Receive Immunotherapy: A Case Series of 24 Patients. SHILAP Revista de lepidopterología. 3(1). 123–133. 2 indexed citations

11.

Lаgopati, Nefeli, Dimitris Veroutis, Νatassa Pippa, et al.. (2023). The Dual Role of Oxidative-Stress-Induced Autophagy in Cellular Senescence: Comprehension and Therapeutic Approaches. Antioxidants. 12(1). 169–169. 29 indexed citations

12.

Giotakis, Evangelos, et al.. (2023). Pediatric Laryngopharyngeal Reflux in the Last Decade: What Is New and Where to Next?. Journal of Clinical Medicine. 12(4). 1436–1436. 5 indexed citations

13.

Papanikolaou, Vasileios, Efthymios Kyrodimos, Nicholas Mastronikolis, et al.. (2023). Anti-EGFR/BRAF-Tyrosine Kinase Inhibitors in Thyroid Carcinoma. Cancer Diagnosis & Prognosis. 3(2). 151–156. 7 indexed citations

14.

Papanikolaou, Vasileios, Aristeidis Chrysovergis, Stylianos Mastronikolis, et al.. (2021). Impact of K-Ras Over-expression in Laryngeal Squamous Cell Carcinoma. In Vivo. 35(3). 1611–1615. 7 indexed citations

15.

Vardas, Emmanouil, Filippo Alongi, Nikolaos Tsoukalas, et al.. (2020). Radiation-Induced Oral Mucositis in Head and Neck Cancer Patients. Five Years Literature Review. Reviews on Recent Clinical Trials. 16(2). 151–165. 3 indexed citations

16.

Papanikolaou, Vasileios, et al.. (2020). Symptomatic retropharyngeal space lipoma. A patient with Madelung disease.. Europe PMC (PubMed Central). 24(2). 91–93. 3 indexed citations

17.

Kyrodimos, Efthymios, Aristeidis Chrysovergis, Nicholas Mastronikolis, et al.. (2020). Impact of Chromosome 9 Numerical Imbalances in Oral Squamous Cell Carcinoma: A Pilot Grid-Based Centromere Analysis. Diagnostics. 10(7). 501–501. 2 indexed citations

18.

Tsiambas, Evangelos, Vasileios Papanikolaou, Aristeidis Chrysovergis, et al.. (2020). Coronavirus in Hematologic Malignancies: Targeting Molecules Beyond the Angiotensin-Converting Enzyme 2 (ACE2) Wall in COVID-19. Pathology & Oncology Research. 26(4). 2823–2825. 6 indexed citations

19.

Nikolaou, Michail, Athanasia Pavlopoulou, Alexandros G. Georgakilas, & Efthymios Kyrodimos. (2018). The challenge of drug resistance in cancer treatment: a current overview. Clinical & Experimental Metastasis. 35(4). 309–318. 432 indexed citations breakdown →

20.

Kyrodimos, Efthymios, et al.. (2013). Cartilage tympanoplasty: a reliable technique for smokers. European Archives of Oto-Rhino-Laryngology. 271(2). 255–260. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact